Kaleido Biosciences Inc
OTC:KLDO
Kaleido Biosciences Inc
OTC:KLDO
Price:
0.0001
USD
Market Closed
Market Cap:
$4.3k
Income Statement
Earnings Waterfall
Kaleido Biosciences Inc
Kaleido Biosciences Inc
Income Statement
Kaleido Biosciences Inc
Kaleido Biosciences Inc
Currency: USD
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+192%
|
1
+34%
|
1
+30%
|
1
-3%
|
1
-31%
|
1
+29%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(39)
|
(50)
|
(61)
|
(71)
|
(84)
|
(89)
|
(87)
|
(86)
|
(79)
|
(80)
|
(80)
|
(83)
|
(88)
|
(88)
|
(89)
|
|
| Selling, General & Administrative |
(10)
|
(15)
|
(19)
|
(21)
|
(24)
|
(23)
|
(22)
|
(23)
|
(22)
|
(24)
|
(24)
|
(23)
|
(24)
|
(22)
|
(21)
|
|
| Research & Development |
(29)
|
(34)
|
(42)
|
(50)
|
(59)
|
(65)
|
(64)
|
(62)
|
(56)
|
(56)
|
(56)
|
(60)
|
(65)
|
(67)
|
(68)
|
|
| Operating Income |
(39)
N/A
|
(50)
-27%
|
(61)
-22%
|
(71)
-17%
|
(84)
-18%
|
(89)
-6%
|
(87)
+2%
|
(86)
+1%
|
(79)
+8%
|
(79)
0%
|
(79)
+0%
|
(82)
-4%
|
(87)
-6%
|
(87)
0%
|
(88)
0%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
0
|
0
|
1
|
1
|
0
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(40)
N/A
|
(51)
-26%
|
(62)
-22%
|
(71)
-15%
|
(84)
-17%
|
(88)
-5%
|
(86)
+2%
|
(86)
+1%
|
(80)
+7%
|
(81)
-1%
|
(82)
-1%
|
(85)
-4%
|
(90)
-6%
|
(90)
+0%
|
(90)
0%
|
|
| Net Income | ||||||||||||||||
| Income from Continuing Operations |
(40)
|
(51)
|
(62)
|
(71)
|
(84)
|
(88)
|
(86)
|
(86)
|
(80)
|
(81)
|
(82)
|
(85)
|
(90)
|
(90)
|
(90)
|
|
| Net Income (Common) |
(40)
N/A
|
(51)
-26%
|
(62)
-22%
|
(71)
-15%
|
(84)
-17%
|
(88)
-5%
|
(86)
+2%
|
(86)
+1%
|
(80)
+7%
|
(81)
-1%
|
(82)
-1%
|
(85)
-4%
|
(90)
-6%
|
(90)
+0%
|
(90)
0%
|
|
| EPS (Diluted) |
-0.73
N/A
|
-1.73
-137%
|
-2.1
-21%
|
-5.49
-161%
|
-2.81
+49%
|
-2.94
-5%
|
-3.36
-14%
|
-2.82
+16%
|
-2.5
+11%
|
-2.28
+9%
|
-2.44
-7%
|
-2.14
+12%
|
-2.11
+1%
|
-2.11
N/A
|
-2.16
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
